Incontinence not improved (generic inverse variance) (women's observation) ‐ oestrogen + other treatments versus placebo · patients with urinary incontinence in post‐menopausal women
Oestrogen + other treatments probably leads to higher incontinence not improved (generic inverse variance) (women's… compared with placebo (moderate certainty).
1 finding from 1 review
Incontinence not improved (generic inverse variance) (women's observations) ‐ Local administration (any incontinence) · patients with urinary incontinence in post‐menopausal women
It is very uncertain whether oestrogen changes incontinence not improved (generic inverse variance) (women's… compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Balance ( · patients with neurodegenerative disease
1 finding from 1 review
Gait Timed Up and Go test · patients with neurodegenerative disease
1 finding from 1 review
Balance ( · patients with neurodegenerative disease
1 finding from 1 review
Gait Time Up and Go test and Stand‐walk‐sit test · patients with neurodegenerative disease
1 finding from 1 review
UPDRS III UPDRS scale (motor score). Scale from: 0 to 56. · patients with neurodegenerative disease
1 finding from 1 review
50% or greater reduction in seizure frequency · people with drug‐resistant generalised tonic‐clonic seizures
Add‐on lamotrigine may leads to higher 50% or greater reduction in seizure frequency compared with placebo (low certainty).
1 finding from 1 review
Seizure freedom · people with drug‐resistant generalised tonic‐clonic seizures
It is very uncertain whether add‐on lamotrigine changes seizure freedom (i.e. total cessation of seizure activity) compared with placebo (very low certainty).
1 finding from 1 review
Treatment withdrawal · people with drug‐resistant generalised tonic‐clonic seizures
It is very uncertain whether add‐on lamotrigine changes treatment withdrawal compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects · people with drug‐resistant generalised tonic‐clonic seizures
It is very uncertain whether add‐on lamotrigine changes adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Time on allocated treatment (retention time) · people with focal or generalized seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Seizure freedom · drug‐naïve people with focal or generalized seizures with solitary cysticercus granuloma
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
50% responder rate · drug‐naïve people with focal or generalized seizures with solitary cysticercus granuloma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects requiring withdrawal/discontinuation of study medication · drug‐naïve people with focal or generalized seizures with solitary cysticercus granuloma
Clobazam showed no clear difference in adverse effects requiring withdrawal/discontinuation of study… compared with phenytoin (low certainty).
1 finding from 1 review
Retention [ · people with focal or generalized seizures
Clobazam showed no clear difference in retention at 12 months compared with carbamazepine (low certainty).
1 finding from 1 review
Seizure freedom · people with focal or generalized seizures
Clobazam showed no clear difference in seizure freedom at 4 weeks compared with carbamazepine (low certainty).
2 findings from 1 review
50% responder rate · people with focal or generalized seizures
Clobazam showed no clear difference in 50% responder rate compared with carbamazepine (low certainty).
1 finding from 1 review
Adverse effects requiring withdrawal/discontinuation of study medication · people with focal or generalized seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time on allocated treatment (retention time) · drug‐naïve people with focal or generalized seizures with solitary cysticercus granuloma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found